EQS-Adhoc: Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in Indonesia

EQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous
Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in Indonesia

08-Dec-2021 / 06:45 CET/CEST
Release of an ad hoc announcement...
Quelle: Börse Online RSS Feed